[LOGO] Dynasil



Contacts:
Patty Kehe
Corporate Secretary
Dynasil Corporation of America
Phone: (617) 668-6855
pkehe@dynasil.com


Dynasil Divests XRF Product Line
Proceeds Used to Reduce Bank Debt


Watertown, Mass., November 7, 2013 - Dynasil Corporation of America
(NASDAQ: DYSL), a developer of sensing, detection and analysis
technology for homeland security, medical and industrial applications,
today completed the sale of the assets of its X-Ray Florescence (XRF)
Lead Paint Detector product line to PROTEC Instrument Corporation, the
U.S. subsidiary of its long-time distributor, French firm Laboratories
PROTEC S.A.

This transaction is a step in the previously announced strategy to
restructure the Company to improve liquidity and pay down bank debt.
The consummation of this divestiture resulted in a payment to Santander
Bank, N.A., the Company's primary lender of approximately $1.2 million,
which reduced the balance of the Company's outstanding indebtedness to
Santander to $5.3 million.  As previously reported, at September 30,
2012, the Company's indebtedness to Santander was approximately $9.0
million.  The Company also has a subordinated $3 million note to
Massachusetts Capital Resource Corporation which has not been paid
down.

"This divestiture is an important step in our strategy to focus our
business and improve our balance sheet," said Peter Sulick, Chairman
and CEO of Dynasil.  "We are very pleased to consummate the sale of the
XRF assets to our long-time strategic partner, Protec.  With this
acquisition, Protec will be substantially expanding their operations in
the U.S.   Protec has been the sole distributor of the LPA in France,
and, as such, is very familiar with the product."

"With the recent spin off of our tissue sealant technology and now the sale
of the XRF assets, Dynasil has reduced outstanding indebtedness while also
eliminating cost," continued Mr. Sulick.  "While we cannot yet report that
we are out of technical default with our creditors, we expect to continue
to make near-term progress toward this goal."

About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures
detection and analysis technology, precision instruments and optical
components for the homeland security, medical and industrial markets
including medical imaging and sensors for non-destructive testing. Dynasil
has an impressive and growing portfolio of issued and pending U.S. patents.
The Company is based in Watertown, Massachusetts, with additional
operations in MA, MN, NY, NJ and the United Kingdom. More information about
the Company is available at www.dynasil.com.


Safe Harbor
This news release may contain forward looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995.  These forward-
looking statements regarding future events and our future results are based
on current expectations, estimates, forecasts, and projections and the
beliefs and assumptions of our management.  These forward-looking
statements may be identified by the use of words such as "plans",
"intends," "may," "could," "expect," "estimate," "anticipate," "continue"
or similar terms, though not all forward-looking statements contain such
words.  The actual results of the future events described in such forward
looking statements could differ materially from those stated in such
forward looking statements due to a number of important factors. These
factors that could cause actual results to differ from those anticipated or
predicted include, without limitation, our ability to develop and
commercialize our products, the size and growth of the potential markets
for our products and our ability to serve those markets, the rate and
degree of market acceptance of any of our products, general economic
conditions, costs and availability of raw materials and management
information systems, our ability to obtain and maintain intellectual
property protection for our products, competition, the loss of key
management and technical personnel, our ability to obtain timely payment of
our invoices to governmental customers, litigation, the effect of
governmental regulatory developments, the availability of financing
sources, our ability to identify and execute on acquisition opportunities
and integrate such acquisitions into our business, and seasonality, as well
as the uncertainties set forth in the Company's 2012 Annual Report on Form
10 K, as amended on February 14, 2013, including the risk factors contained
in Item 1a, the Company's Quarterly Reports on Form 10-Q filed on February
13, 2013, May 15, 2013 and August 12, 2013 and from time to time in the
Company's other filings with the Securities and Exchange Commission. The
Company disclaims any intention or obligation to update any forward-looking
statements, whether as a result of new information, future events or
otherwise.